Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price t...
On November 6, 2025, DENTSPLY SIRONA Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Report&...
JP Morgan analyst Lilia-Celine Lozada maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target fro...
Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and lowers the price target from ...
William Blair analyst Brandon Vazquez downgrades Dentsply Sirona (NASDAQ:XRAY) from Outperform to Market Perform.
Dentsply Sirona stock falls after weak Q3 results, lowered 2025 earnings outlook and CFO exit as CEO launches a return-to-growt...
Dentsply Sirona (NASDAQ:XRAY) lowers FY2025 Adj EPS guidance from $1.80-$2.00 to $1.60 vs $1.88 analyst estimate. Affirms FY202...
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....
